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DOI: 10.1039/c2an35913hMercury toxicity and its implications in development are a major concern, due to the major threat to
ecosystems and human health that this compound represents. Although some of the effects of
methylmercury (MeHg) exposure have been extensively studied, the molecular mechanisms of
interaction between this compound and developing organisms are still not completely understood. To
provide further insights into these mechanisms, we carried out a quantitative proteomic study (iTRAQ)
using zebrafish larvae exposed to 5 mg L1 and 25 mg L1 MeHg as a model. In this study, a
multidimensional approach combining isoelectric focusing (IEF) and strong cation exchange (SCX)
followed by reversed phase liquid chromatography prior toMALDI TOF/TOF analysis was employed,
which resulted in a substantial increase in proteome coverage. Among the proteins identified, 71 were
found de-regulated by more than 1.5-fold, and implicated in embryonic development, protein synthesis,
calcium homeostasis and energy production. Furthermore, morphological and histological analysis of
exposed larvae was carried out, reflecting changes such as smaller swim bladder, remaining yolk, bent
body axis and accumulation of blood in the heart, among others.Introduction
Toxicity, biochemical behavior and transport of mercury in the
environment are clearly dependent on its chemical form.1 Inor-
ganic mercury (Hg2+) and monomethylmercury (CH3Hg
+) are
the two most abundant species found in biological samples.2 It is
well known that organomercurial compounds are more harmful
than inorganic mercury; however, the latter can also be bio-
methylated by aquatic organisms, thus making fish consumption
the major source of methylmercury for humans.3 Application
of the bioconcentration test 305 (proposed as a standard method
by the OECD to adult fish exposed to methylmercury) has
demonstrated the high capacity of this compound to be accu-
mulated.4 Although the bioconcentration factor provides valu-
able information about the bioaccumulative properties of a
chemical, additional information on the mechanisms of interac-
tion and the effects caused in living organisms are required toaDepartment of Analytical Chemistry, Faculty of Chemistry, Complutense
University ofMadrid, 28040Madrid, Spain. E-mail: jlluque@quim.ucm.es;
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5302 | Analyst, 2012, 137, 5302–5311evaluate the toxicity of a given compound. In our case, it is
known that ingested mercury can interact with proteins and
enzymes due to its strong affinity for sulfur, causing organ
dysfunction and a devastating effect on the whole central
nervous system, particularly the developing brain.5 The genera-
tion of reactive oxygen species (ROS) by MeHg as well as the
active involvement of the mitochondria in the process have been
shown in previous studies.6,7 Specific proteins and mechanisms
related to methylmercury-induced cell death7 and neurotox-
icity8,9 have also been reported using different biochemical
approaches. However, a deeper insight into the mechanisms by
which methylmercury exerts its toxicity, particularly during
embryonic development, would be highly desired.
Quantitative proteomics appears as a suitable tool for this
purpose since hundreds of proteins can be analyzed in a single
experiment,10 thus allowing the identification of those with an
altered expression induced by MeHg. These proteins would
represent not only potential targets for the study of specific
mechanisms by additional biochemical methods, but also as
potential biomarkers of MeHg ecotoxicity. The application of
advanced proteomic strategies to the toxicological field has been
very discrete so far; although in other fields, quantitative
proteomics is emerging as a reference exploratory technique.11,12
As for the study of MeHg-induced toxicity, proteomics has only
been applied using gel-based approaches,13,14 which have
important limitations regarding the number of potential
identifications.This journal is ª The Royal Society of Chemistry 2012
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View Article OnlineBased on all of the above, we have selected a state-of-the-art
quantitative proteomic approach as a discovery strategy, that
circumvents the limitations of gel-based proteomic approaches,
in order to identify target proteins associated with the mecha-
nisms involved in the developmental toxicity induced by MeHg
as well as potential biomarkers of ecotoxicity. iTRAQ15 (isobaric
tags for relative and absolute quantification) was used as the
unbiased quantitative proteomic approach in this study. This
method allows isotopic labeling of different tissue samples and
thus, protein quantitation of up to 8 samples simultaneously in a
single experiment.16 The use of bioinformatic tools also allowed
us to identify the biological processes and functions affected
upon MeHg exposure. We have selected zebrafish larvae as a
model since it has been recently proposed as an alternative to
adult fish in the previous OECD test guideline because of the
drastic time reduction in the bioaccumulation test (72 hours vs.
42 days when using adult fish) and other additional advantages
such as (i) sample availability (each female is capable of laying
200–300 eggs per week), (ii) fast embryonic development and (iii)
a high similarity on the protein level compared to humans
(mostly protein homology is above 70%). This makes it a very
suitable model for proteomic analysis of MeHg effects in
vertebrates.
In our work, we have evaluated changes in the proteome of
zebrafish larvae exposed to 5 and 25 mg L1 of MeHg as
compared to control samples. The criteria for selecting 5 and
25 mg L1 exposure concentrations is based on previous experi-
ments done by increasing MeHg levels of exposure. The selected
levels allow the observation of changes in the zebrafish embryo
within a reasonable time for the assay and without promoting
mortality among zebrafish embryo (A LC50 of 250 mg L1 has
been reported for MeHg for zebrafish embryo).17 The results
obtained from the proteomic approach, have been supported by
morphological and histological analysis carried out on the
MeHg-exposed larvae; thus helping to gain a deeper insight into
the developmental toxicity induced by MeHg.Materials and methods
Sample preparation
Zebrafish (Danio rerio) larvae (WIK strain) were kindly provided
by the Spanish National Cardiovascular Research Center
(CNIC, Madrid, Spain). Exposure media were prepared in order
to have a similar composition to fresh river water, containing
46.4 mg L1 of CaCl2, 275.2 mg L
1 of NaCl, 12.2 mg L1 of
KCl and 78.4 mg L1 of MgSO4. Based on OECD guidelines, the
culture conditions in this medium were: 26  2 C, dissolved
oxygen$ 60% and pH 6–8.5 (before and after renewal). MeHgCl
standard solutions used for exposure tests were prepared in
culture media daily by making appropriate dilutions of MeHgCl
stock standard solution at 1000 mg L1 prepared in methanol.
The stock solution was stored in the dark at 18 C. Zebrafish
larvae at 72 h post-fertilization (hpf) were exposed to MeHg for
72 hours in Petri dishes containing different concentrations of
MeHg (0 mg L1, 5 mg L1 and 25 mg L1), after which the larvae
(6 days post-fertilization – 6 dpf) were collected and prepared for
the proteomic study or for the microscopic and histological
analysis. To avoid potential variability associated with the use ofThis journal is ª The Royal Society of Chemistry 2012different Petri dishes for each condition, the samples used were
pools of larvae grown in different dishes. Concentrations of
MeHg in larvae after 72 h of exposure were estimated applying
the bioaccumulation factor (BCF) previously calculated by ICP-
MS in similar samples at similar exposure times.8 Considering a
BCF value of 2500, the concentration of MeHg in larvae should
be around 12.5 mg g1 and 62 mg g1, for larvae exposed to 5 and
25 mg L1, respectively.Protein extraction and peptide labeling
Zebrafish larvae (20 per condition) were resuspended in 200 mL
of ice-cold RIPA buffer (20 mM Tris–HCl pH 7.4, 37 mMNaCl,
2 mM EDTA, 1% Triton X-100, 10% glycerol, 0.1% SDS and
0.5% Na deoxycholate) containing protease and phosphatase
inhibitors. Samples were incubated on ice for 15 min and
centrifuged at 4 C and 16 000g for 10 min. This step was
repeated twice and supernatants containing the protein fraction
were cleaned-up by acetone precipitation with six volumes of ice-
cold acetone. Pellets were dissolved in 0.5 M triethylammonium
bicarbonate (TEAB). For the 4-plex iTRAQ experiments, zebrafish
larvae from the same genetic background (WIK, wild type strain
previously established) were either used as controls or exposed to 5
and 25 mg L1 of MeHg for 72 hours. Biological replicates were
carried out with larvae from different matings at different times and
in different Petri dishes. Protein concentration was determined by
the Bradford assay using BSA as standard. Protein digestion and
iTRAQ labeling was performed according to the manufacturer’s
protocol (Applied Biosystems) and as described elsewhere.18 Each
tryptic digest was labeled with one isobaric amine-reactive tag as
follows: Tag114 – Control 1, Tag115 – Control 2, Tag116 – 5 mg L
1
MeHg and Tag117 – 25 mg L
1 MeHg. Labeling was done in
two sets of samples in order to obtain two biological replicates
(A and B).Strong cation exchange and OFFGEL fractionation
One half of the sample, equivalent to 50 mg of protein was
separated by strong cation exchange chromatography (SCX) as
in previous studies.19 pI-based peptide separation was performed
by a 3100 OFFGEL Fractionator System (Agilent Technologies,
B€oblingen, Germany) with a 24-well set-up. The 24 cm long IPG
gel strips (GE Healthcare, M€unchen, Germany) with a
3–10 linear pH range were rehydrated for 15 min with the Peptide
IPG Strip Rehydradation Solution according to the manu-
facturer’s protocol. Subsequently, 150 mL of the sample was
loaded in each well. Isoelectrofocusing (IEF) of the peptides was
performed at 20 C and 50 mA until the 50 kV h level was reached.
After focusing, the 24-peptide fractions were withdrawn and the
wells rinsed with 100 mL of a solution of water–methanol–formic
acid (49/50/1). Rinsing solutions were pooled after 15 min with
their corresponding peptide fractions. All fractions were evapo-
rated by centrifugation under vacuum and reconstituted in 0.1%
TFA 3% ACN prior to clean up. Solid phase extraction and salt
removal was performed with home-made columns based on
Stage Tips with C8 Empore Disks (3M, Minneapolis, MN) filled
with R2 resin (Applied Biosystems). The bound peptides were
washed with 0.1% TFA and eluted with 0.1% TFA 70% ACN.
Eluates were evaporated to dryness and maintained at 4 C.Analyst, 2012, 137, 5302–5311 | 5303
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View Article OnlineReversed-phase liquid chromatography
Each fraction from the SCX or IEF separation was resuspended
in 0.1% TFA 3%ACN buffer and separated on an Ultimate 3000
nano-LC system (Dionex-LC Packings, Amsterdam, The Neth-
erlands) equipped with a Probot MALDI spotting device
(Dionex-LC Packings). In order to pre-concentrate and desalt
the samples before switching the pre-column in line with the
separation column, 20 mL from each dissolved SCX and IEF
fraction was loaded onto a reversed-phase Monolithic PS-DVB
200 mm ID  5 mm peptide trapping cartridge (Dionex-LC
Packings), and washed for 8 min at 20 mL min1 with loading
buffer (0.05% HFBA). The peptides were eluted from a RP
Monolithic PS-DVB column 200 mm ID  5 cm analytical
column (Dionex-LC Packings) by application of a binary
gradient with a flow rate of 2.5 mL min1. Buffer A was 2% ACN
in 0.05% TFA, buffer B was 50% ACN with 0.04% TFA. The
gradient used was 0–8 min 0% B, 8–39 min 65% B, 39–45 min
90% B and 45–55 min 0% B. For IEF fractions, 2% of buffer B
was used during the washing step and column equilibration. The
column effluent was mixed directly with the MALDI matrix
solution (3 mg mL1 a-cyano-4-hydroxycinnamic acid in 70%
ACN with 0.1% TFA) at a flow rate of 2.5 mL min1 through a
m-Tee connection, before spotting onto 1664-well stainless steel
MALDI target plates (Applied Biosystems) using a Probot micro
fraction collector (Dionex-LC Packings) with a speed of 5 s per
well. The matrix contained 10 mM NH4H2PO4 and 10 nmol of
P14R synthetic peptide (monoisotopic (M + H)+ ¼ 1533.8582;
C76H113N18O16) (Sigma, St. Louis, MO, USA) as an internal
standard for mass calibration.
Protein identification and quantification by mass spectrometry
MALDI target plates were analyzed using a 4800 Analyzer
equipped with TOF/TOF ion optics (ABSCIEX. Concord,
Ontario, Canada), and 4000 Series Explorer software version
3.5.1. as described elsewhere.18 Protein identification and relative
quantification were performed with the ProteinPilot software
(version 3.0; ABSCIEX) using the Paragon algorithm as
described in detail in the ESI† ‘‘Protein ID/QT Methods’’.
Precursor and fragment ion mass tolerance were set to 0.2 and 0.4
Da, respectively. The results were then exported into Excel for
manual data interpretation. Although relative quantification and
statistical analysis were provided by the ProteinPilot 3.0 soft-
ware, an additional 1.5-fold change cutoff for all iTRAQ ratios
was selected to classify proteins as up- or down-regulated.
Statistical analysis
The relative protein levels between the iTRAQ-labeled samples
were estimated based on the quantitative ratios. The average ratio
for each protein was calculated by ProteinPilot based on the
ratio values for each peptide. These values were determined based
on the peak area ratios on the MS/MS spectra between ions m/z
114.1, 115.1, 116.1 and 117.1 (corresponding to the different
iTRAQ tags). ProteinPilot also provided the P-value for each
protein, which measures the certainty that the average ratio differs
from 1. The smaller the P-value, the more likely any differential
expression observed is real. Proteins showing a P-value <0.05 were
considered de-regulated by the ProteinPilot software. However,5304 | Analyst, 2012, 137, 5302–5311in our experiment, an additional cut-off of 1.5-fold change was
selected due to the variability associated with our samples. Further
details on the statistical analysis are given in the ESI.†
Bioinformatic-based functional analysis
Protein ID mapping was carried out by the web-free application
Protein Identifiers Cross-Reference (PICR) to establish the
cellular localization, the biological function and the biological
process in which the identified proteins are involved based on
Gene Ontology annotations. In order to know potential intra-
cellular signaling pathways or molecules affected by MeHg
exposure, the significantly de-regulated proteins with their NCBI
accession number and the ratio changes were imported into the
Ingenuity Pathway Analysis (IPA) software package (Ingenuity
Systems Inc.).
Histological analysis
For histological analyses by light microscopy (LM), larvae were
fixed in 4% paraformaldehyde (PFA) in PBS (pH 7.2) at 4 C
overnight and washed three times in PBS. The embryos were
dehydrated in a standard ethanol series, infiltrated and embedded
in paraffin for sectioning. For H&E staining, 5 mm sections were
processed according to standard procedures.
Results and discussion
Combination of SCX and IEF increase proteome coverage
In this study, a multidimensional approach combining IEF and
SCX followed by reversed phase liquid chromatography was
used for extensive peptide separation (Fig. 1). A total number of
1189 and 1141 proteins were identified by ProteinPilot in bio-
logical replicates A and B, respectively, after the overall analysis
of all spectra acquired in the study. For further analysis, only
proteins identified with 2 or more distinct peptides were
considered, resulting in 667 and 594 proteins identified in bio-
logical replicates A and B, respectively. A total of 442 identified
proteins were common to both biological replicates, showing a
significant overlap between samples (Fig. 2A).
Peptide fractionation combining IEF and SCX has been
shown to increase protein identification over classic multidi-
mensional approaches such as MudPIT, since three distinct
separation techniques are employed. 484 and 350 proteins were
identified in replicate A after the analysis of data obtained from
SCX and IEF fractionation samples, respectively (Fig. 2B). In
replicate B, 389 and 339 proteins were independently identified
from SCX and IEF approaches (Fig. 2C). Hence, SCX provided
more protein identifications, thus confirming that the degree of
proteome coverage is proportional to the extent of peptide
fractionation (ESI, Fig. S1†).19
Fig. 2B and C also show the overlapping of the fractionation
techniques, since only 38% of all the proteins identified in repli-
cate A and 35% of all the proteins identified in replicate B were
detected using both approaches.
As a result, we can conclude that the number of proteins
identified is significantly high after using complementary tech-
niques for sample fractionation before RP separation, which is
the ultimate goal of discovery-oriented experiments.This journal is ª The Royal Society of Chemistry 2012
Fig. 1 General scheme of the discovery platform used based on iTRAQ in combination with SCX and IEF separation andMALDI-TOF/TOF analysis.
Fig. 2 Venn diagrams depicting the overlap of proteins (A) between
replicate A and replicate B when combining spectra from SCX and IEF
separations, (B) between SCX and IEF approaches in replicate A and (C)
between SCX and IEF approaches in replicate B. Only proteins identified
with two or more peptides with 95% confidence were considered.
This journal is ª The Royal Society of Chemistry 2012
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View Article OnlineProtein abundance changes upon MeHg exposure
We analysed the larval zebrafish proteome in two large-scale
iTRAQ biological replicates (20 zebrafish larvae per condition).
In these experiments control larvae were compared to larvae
exposed to 5 mg L1 and 25 mg L1 of MeHg for 72 h. Altogether
819 proteins were identified in the two iTRAQ experiments with
two or more unique peptides, which was the criteria considered
for valid hits. Using 1.5 as the threshold for a significant fold
change due to the expected heterogeneity of the samples, 18
proteins were found de-regulated upon 5 mg L1 MeHg exposure,
of which half of the proteins were up-regulated and the other half
down-regulated (Table 1). As for the larvae exposed to 25 mg L1
of MeHg, we found 58 de-regulated proteins, from which 42 were
up-regulated (Table 2) and 16 down-regulated (Table 3).
Detailed information of the de-regulated proteins is provided as
ESI (Tables S1 and S2†). As expected, the increase in MeHg
concentration was directly correlated with the increase in the
number of de-regulated proteins. However, the identified
de-regulated proteins were significantly different between larvae
treated with the two different MeHg concentrations, thus
reflecting differences in the activation of different biological
functions due to the treatment. This can be explained by the fact
that our study was carried out on a developing organism, which
means that the same organs and functions may be affected
differently at different concentrations of MeHg due to the
different needs of every organ at different developmental stages.
These results correlate well with the morphological and histo-
logical changes observed (see below) under both conditions.
Regarding the iTRAQ ratio distribution, most of the identified
proteins were within an iTRAQ ratio close to 1, as expected for a
1 : 1 : 1 : 1 mixture.Analyst, 2012, 137, 5302–5311 | 5305
Table 1 Proteins found de-regulated in 6 dpf zebrafish larvae exposed to 5 mg L1 of MeHg
Accession
number (gi)
Common
name Protein name
Average
iTRAQ
ratio
iTRAQ
ratio A P-value A
Number of
peptides A
iTRAQ
ratio B P-value B
Number of
peptides B
47550733 serbp1 SERPINE1 mRNA binding
protein 1
2.91 NQ NQ NQ 2.91 0.018 5
18858587 eef1a Elongation factor 1-alpha 2.13 2.52 0.608 4 1.74 0.021 6
18858197 gstp1 Glutathione S-transferase pia 1.76 1.70 0.002 8 1.82 0.004 6
18859297 pvalb2 Parvalbumin-2a 1.68 1.65 0.001 5 1.71 0.011 4
157787181 ckmb Muscle creatine kinase b 1.66 1.72 0.007 5 1.60 0.208 2
33636707 pvalb9 Parvalbumin 9a 1.62 1.62 0.051 3 NQ NQ NQ
55742597 eif5a2 Eukaryotic translation initiation
factor 5A-2
1.59 1.54 0.253 2 1.64 0.474 3
31795559 tnnt3b Troponin T3b, skeletal, fast
isoform 2
1.54 1.58 0.008 5 1.50 0.026 5
18858947 krt4 Keratin 4 1.54 1.67 0.014 7 1.41 0.979 4
113678458 vtg2 Vitellogenin 2 isoform 1 1.54 1.54 0.001 20 1.54 0.001 23
156713467 vtg7 Vitellogenin 7 1.56 1.54 0.079 6 1.58 0.014 10
68448530 vtg5 Vitellogenin 5 1.56 1.43 0.074 11 1.69 0.001 15
189523697 ttnb Titin b 1.56 NQ NQ NQ 1.56 0.037 6
303227889 vtg6 Vitellogenin 6 1.59 1.55 0.059 5 1.63 0.008 9
68444085 mfap4 Microfibrillar-associated
protein 4-like
1.79 NQ NQ NQ 1.79 0.026 2
66472252 smyhc1 Slow myosin heavy chain 1 1.85 1.95 0.022 3 1.75 0.045 7
189523699 ttna Titin aa 2.38 NQ NQ NQ 1.32 0.359 6
238776848 myhz1.2 Myosin, heavy
polypeptide 1.2a
3.85 3.85 0.0020 11 NQ NQ NQ
a Proteins de-regulated at both 5 and 25 ppb of MeHg exposure.
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View Article OnlineFunctional analysis
The functional annotation of the 71 differentially expressed
proteins in control vs. MeHg exposed larvae was assigned using
the web-free application Protein Identifiers Cross-Reference
(PICR) based on the Gene Ontology database. Three main types
of annotations were obtained: the cellular compartment, the
molecular function and the biological process (Fig. 3). A high
number of de-regulated proteins (32%) were localized in the
cytosol and the cytoskeleton, supporting the relevance of these
compartments in the mechanisms involved in MeHg-induced
toxicity (Fig. 3A). The ontology analysis indicated the relevance
and diversity of molecular functions of these proteins, such as
catalytic activity (34%), nucleotide binding (16%) and transport
activity (11%) (Fig. 3B). The data in Fig. 3C are supported by
previous studies on the impact of MeHg exposure11–13 since
several biological processes that appeared to be de-regulated
proteins include the metabolic process (32%), transport (14%)
and response to stimulus (14%). Moreover, we identified
processes that are closely related to methylmercury toxicity, such
as developmental processes (4%) and apoptosis (9%). The data
identifying de-regulated proteins were further analyzed using the
IPA software to scrutinize for key biological processes and
pathways of relevance regarding the mechanisms of toxicity
associated with MeHg. In addition, the software was used to
statistically rank the various pathways in order of significance.
Therefore, 58 ID proteins were imported into the software and 38
were mapped by the knowledge database functions among those
proteins included cellular assembly and organization, including
formation of filaments (si:dkey-46g23.2, fn1b, krt18, pfn2l, ttnb),
gastrointestinal disease, hepatic system disease including damage
of liver (c3, krt18, krt8) and neurological disease, with5306 | Analyst, 2012, 137, 5302–5311sub-functions such as movement disorders and neuromuscular
diseases (si:dkey-46g23.2, AK1, c3, gstp1, nme2b.1, pfn2l, rpia,
uchl1). The most relevant functions associated with the top
network generated from the analysis (ESI, Fig. S2†) include
cellular assembly and organization; cellular function and main-
tenance; and cellular movement. These data are consistent with
the morphological and histological alterations observed in
exposed larvae, and with the well-known neurotoxic20–22 and
hepatotoxic7,23 properties of MeHg.
In order to correlate both the proteomic results and the
histological observations with the functional analysis, we used
the databases ZFin (http://zfin.org)24 and ZF-Espresso (http://
zf-espresso.tuebingen.mpg.de/). These repositories contain
in situ hybridation studies showing organ-specific expression
patterns. References supporting the organ-specific location of
proteins found deregulated uponMeHg exposure are included as
ESI (Table S3†).Histological analysis
6 dpf control larvae showed the typical developmental
morphology at this developmental stage (Fig. 4A), whereas 6 dpf
zebrafish larvae exposed to 5 mg L1 (Fig. 4B) and 25 mg L1
(Fig. 4C) showed a significantly smaller swim bladder (not
macroscopically visible) (ESI, Fig. S3†) and a morphological
change of the upper jaw (flattening of the anterior part), this was
more pronounced in larvae exposed to the higher concentration.
Moreover, these larvae showed a bent body axis above the trunk
region (see arrows in Fig. 4C). Previous studies where embryos of
fathead minnow,25 killfish26 and zebrafish27 were exposed to
different concentrations of Hg showed similar features includingThis journal is ª The Royal Society of Chemistry 2012
Table 2 Up-regulated proteins in 6 dpf zebrafish larvae exposed to 25 mg L1 of MeHg
Accession
number (gi)
Common
name Protein name
Average
iTRAQ
ratio
iTRAQ
ratio A P-value A
Number of
peptides A
iTRAQ
ratio B P-value B
Number of
peptides B
189521249 Hypothetical protein 15.10 16.28 0.025 4 13.92 0.136 4
24308537 zp2.4 Zona pellucida glycoprotein 2.4 7.44 NQ NQ NQ 7.44 0.029 9
47086603 si:dkeyp-
50f7.2
ZPA domain containing protein
isoform 2
7.76 7.76 0.017 7 NQ NQ NQ
41055329 chia Acidic chitinase 6.04 6.42 0.009 5 1
94536701 si:dkeyp-
50f7.2
ZPA domain containing protein
isoform 1
6.04 NQ NQ NQ 6.04 0.011 5
125816799 si:dkey-
46g23.2
si:dkey-46g23.2 5.83 7.58 0.004 3 4.08 0.003 5
61651682 fn1b Fibronectin 1b 3.65 3.65 0.038 6 NQ NQ NQ
226442998 he1b Hatching enzyme 1b 3.12 NQ NQ NQ 3.12 0.004 1
288856329 myhz1.1 Myosin, heavy polypeptide 1.1 3.05 2.85 0.008 13 3.25 0.001 4
238776848 myhz1.2 Myosin, heavy polypeptide 1.2a 2.30 NQ NQ NQ 2.30 0.021 13
50355968 calrl Calreticulin like 2.15 2.15 0.074 5 NQ NQ NQ
41054259 pdia4 Protein disulfide-isomerase A4 2.14 2.07 0.132 7 2.21 0.365 5
82658290 hmgb2 High-mobility group box 2 2.11 2.11 0.029 5 NQ NQ NQ
292610077 c3 Complement component 3 2.08 1.87 0.178 4 NQ NQ NQ
53749651 ppib Peptidyl-prolyl cis–trans isomerase B 2.06 2.07 0.017 6 2.05 0.009 5
18858197 gstp1 Glutathione S-transferase pia 2.05 1.91 0.002 8 2.19 0.209 6
18859107 nme2b.1 Nucleoside diphosphate kinase A 2.01 1.94 0.005 4 2.08 0.087 4
125827065 si:dkey-
88l16.3
si:dkey-88l16.3 1.98 1.98 0.039 2 NQ NQ NQ
33636707 pvalb9 Parvalbumin 9a 1.95 1.97 0.230 3 1.93 0.346 3
292618718 vtg3 Vitellogenin 3, phosvitinless 1.86 1.86 0.006 19 NQ NQ NQ
40254675 lmnb1 Lamin-B1 1.84 1.84 0.406 5 NQ NQ NQ
189523699 ttna Titin aa 1.83 NQ NQ NQ 1.83 0.592 6
82524272 c3b Complement component c3b 1.81 NQ NQ NQ 1.81 0.005 2
189535920 flna filamin A, alpha 1.80 2.07 0.002 19 1.53 0.758 16
41393111 uchl1 Ubiquitin carboxyl-terminal
hydrolase isozyme L1
1.79 1.72 0.009 4 1.86 0.505 2
292619135 flnb Filamin B, like, partial 1.78 NQ NQ NQ 1.78 0.009 3
30410758 krt18 Keratin, type I cytoskeletal 18 1.73 1.73 0.039 3 NQ NQ NQ
67972636 hnrnpab Heterogeneous nuclear
ribonucleoprotein A/B
1.72 1.65 0.273 2 1.79 0.027 2
18859297 pvalb2 Parvalbumin-2a 1.62 1.52 0.002 5 1.72 0.007 4
56118638 pfn2l Profilin-2 1.62 1.62 0.005 2 NQ NQ NQ
41151982 mvp Major vault protein 1.60 1.39 0.045 6 1.81 0.049 6
65301457 prdx3 Thioredoxin-dependent peroxide
reductase, mitochondrial
1.57 1.57 0.119 2 NQ NQ NQ
48597012 rpl23a 60S ribosomal protein L23a 1.57 1.44 0.034 3 1.70 0.005 1
41152461 rpl7a 60S ribosomal protein L7a 1.56 1.56 0.084 1 NQ NQ NQ
41386743 eef2b Eukaryotic translation elongation
factor 2b
1.56 1.56 0.080 8 NQ NQ NQ
292611632 BX901973.4 Hypothetical protein LOC325896 1.56 1.44 0.043 4 1.68 0.007 5
68442739 his4r Histone H4 replacement-like 1.55 1.48 0.096 5 1.62 0.003 2
41053774 erp44 Endoplasmic reticulum resident
protein 44
1.54 1.54 0.226 3 NQ NQ NQ
a Proteins de-regulated at both 5 and 25 ppb of MeHg exposure.
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View Article Onlineflexure of the embryonic axis,25 increase of the spinal curvature26
and abnormalities along the finfold,27which is consistent with the
fact that some of the proteins found de-regulated in our study
were located in the musculature system (ESI, Table S3†). Other
organs such as brain, ear and liver seemed to be affected by
MeHg exposure as compared to control larvae that showed
typical developmental morphology (Fig. 4D). The fold between
the telencephalon and the tectum was absent in larvae exposed to
5 mg L1MeHg and a slight hammerhead was observed (Fig. 4E).
These changes were even more dramatic in the zebrafish larvae
exposed to 25 mg L1 (Fig. 4F). In addition, in the larvae exposed
to 25 mg L1 MeHg the shape of the ear was irregular and the
liver size was increased. Proteins including c3, gstp1, c3b and
rbp4, that are located in the liver showed an alteration in theirThis journal is ª The Royal Society of Chemistry 2012expression levels after MeHg exposure (ESI, Table S3†). Larvae
exposed to 25 mg L1 also showed an accumulation of blood in
the heart region (indicated by an arrow), thus suggesting a
possible defect in the cardiac output (Fig. 4F). Devlin and
Mottet28 have previously observed that embryos exposed to
MeHg presented abnormalities associated with the circulatory
system: the heartbeat was irregular and blood could not make a
complete circuit through the heart without difficulty. This
observation may be related to the overexpression suffered by the
nucleoside diphosphate kinase A, located in the heart, upon
MeHg exposure (ESI, Table S3†).
Morphological and histological analyses of the eye did not
reveal obvious changes after treatment with either 5 mg L1 or
25 mg L1 MeHg (ESI, Fig. S4†). 6 dpf old zebrafish larvae underAnalyst, 2012, 137, 5302–5311 | 5307
Table 3 Down-regulated proteins in 6 dpf zebrafish larvae exposed to 25 mg L1 of MeHg
Accesion
number (gi)
Common
name Protein name
Average
iTRAQ
ratio
iTRAQ
ratio A P-value A
Number of
peptides A
iTRAQ
ratio B P-value B
Number of
peptides B
41152439 rpl10a 60S ribosomal protein L10a 1.49 1.49 0.055 3 NQ NQ NQ
71834286 apobl Apolipoprotein B, like 1.54 1.44 0.142 46 1.64 0.242 47
292619319 rbp4 Retinol-binding protein 4, plasma-like 1.54 NQ NQ NQ 1.54 0.014 2
45387573 pvalb1 Parvalbumin isoform 1d 1.54 1.58 0.037 3 1.50 0.036 2
51571925 AK1 Adenylate kinase isoenzyme 1 1.56 1.54 0.063 4 1.58 0.229 3
48762657 eno1 Alpha-enolase 1.59 NQ NQ NQ 1.59 0.009 2
54261787 ilf2 Interleukin enhancer-binding factor 2 1.61 1.72 0.163 3 1.50 0.054 5
292617604 crygc Crystallin, gamma C-like 1.64 1.50 0.219 1 1.69 0.017 2
18858425 krt5 Keratin 5 1.67 NQ NQ NQ 1.67 0.011 3
41054746 gatm Glycine amidinotransferase,
mitochondrial
1.69 1.69 0.106 2 NQ NQ NQ
47550793 nnt NAD(P) transhydrogenase, mitochondrial 2.08 2.08 0.109 4 NQ NQ NQ
33504543 atp6v1ba V-type proton ATPase subunit B 2.13 NQ NQ NQ 2.13 0.065 2
62632719 hbbe3 Hemoglobin beta embryonic-3 2.22 2.32 0.049 4 2.12 0.033 3
27545277 eef1g Elongation factor 1-gamma 2.44 2.08 0.084 6 2.80 0.127 7
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View Article Onlineincident light conditions showed the typical pattern and intensity
of iridophores in the eye and in the body. Shape and size of the
eye was found to be wild-type-like (ESI, Fig. S4a†). 6 dpf
zebrafish larvae exposed to 5 mg L1 and 25 mg L1 MeHg dis-
played a slight reduction of iridophores in the eye (ESI, Fig. S4e
and S4f†) and in the body. However, no differences in melano-
cyte pigmentation or melanin distribution were observed (data
not shown). Furthermore, no difference in shape and size of the
eye or the pupil were detected in MeHg exposed larvae as
compared to controls. This was confirmed by histological anal-
yses (data not shown).
Zebrafish larvae exposed to 25 mg L1 displayed a significantly
smaller swim bladder (sb) (Fig. 5). The remaining yolk (y) at this
age indicated a developmental delay of the exposed larvae, which
is also supported by previous studies where a delay in develop-
ment was observed due to MeHg and HgCl2 treatment.
28–30 Liver
(li) cells showed increased vesicular areas which might indicate an
increased liver cell size and disturbed liver cell function (Fig. 5B).
The inset in B shows a magnification of the gut (g) where cells
containing big vacuoles appeared after exposure. Zebrafish
larvae exposed to 25 mg L1 developed a defect in the myotomes
as well as in the notochord (Fig. 5D). Myotomes were smaller in
size and the boundaries in-between somites were hardly visible.
Myofibers within the myotomes appeared to be loosely packed.
The high magnification of the notochord (insert in Fig. 5D)
showed a defect in the palisade-like structures of the chon-
drocytes reflecting the bend body-axis (see also arrows in
Fig. 4C). The chondrocytes of the notochord were also affected
in coho salmon embryos exposed to MeHg in the study carried
out by Devlin and Mottet28 These dysfunctions probably lead to
the abnormal swimming behavior observed in the 25 mg L1
treated zebrafish larvae.MeHg exposure affects embryonic development
Previous studies have shown that MeHg exposure affects the
developmental process of fathead minnow,28 coho salmon,31
rainbow trout32 and carp embryos,33 causing in all the cases a
clear developmental delay as compared to control embryos.
These data support our findings using zebrafish, where, as5308 | Analyst, 2012, 137, 5302–5311commented before in the histological analysis, a remaining yolk
was observed in larvae exposed to 25 mg L1 MeHg.
One of the proteins that appeared clearly up-regulated in
larvae exposed to 25 mg L1 MeHg (3-fold compared to control
larvae) is he1b which plays a crucial role in digesting the chorion
during the hatching process of fish.34 Previous studies have
demonstrated that not only mercury35 but also other heavy
metals such as cadmium can affect negatively the hatching
process in fish.36 Rbp4 appeared down-regulated in zebrafish
larvae exposed to 25 mg L1 of MeHg. The inhibition of this
protein has been associated with stage-specific malformations of
the vitelline vessels, the cranial neural tube, and the eye. Reduced
levels of Rbp4 could be the cause for the morphological and
histological alterations, e.g. malformation of the jaw and the
notochord observed in our MeHg-exposed larvae.37
Other proteins related to development and found de-regulated
in our experiment were zp2.4 and si:dkeyp-50f7.2. Both of them
are associated with the zona pellucida or chorion and showed a
significant up-regulation. Degradation of the chorion is a crucial
step during development; thus, the presence of high amounts of
these proteins in MeHg-exposed larvae as compared to controls,
correlates well with the developmental delay observed as these
proteins were expected to be down-regulated at this develop-
mental stage.Alteration of the protein synthesis mechanism due to MeHg
exposure
Zebrafish larvae exposed to 25 mg L1 MeHg showed a signifi-
cant de-regulation of ribosomal proteins such as rpl32a, rpl7a
(up-regulated) and rpl10a (down-regulated) involved in protein
synthesis. It is known that rpl7a can induce apoptosis.31Our data
suggest that apoptosis associated with methylmercury toxicity
might be mediated by rpl7a.32,33 The observed relationship
between MeHg and the differential expression of ribosomal
proteins in skeletal muscles of zebrafish38 and hepatic cells39 have
also been previously pointed out. In addition, it has also been
demonstrated that a reduced activity in ribosomal proteins may
lead to deformation of the brain and body trunk,40 which
correlates well with our results in the histological analysis.This journal is ª The Royal Society of Chemistry 2012
Fig. 3 Classification of the 76 de-regulated proteins according to: (A)
cellular compartment. C, cytosol; I, intracellular; CS, cytoskeleton; MB,
membrane; N, nucleus; ES, extracellular space; MT, mitochondria. (B)
Molecular function. CA, catalytic activity; NB, nucleotide binding; TA,
transporter activity; NAB, nucleic acid binding; MB, metal binding;
SMA, structural molecule activity; PB, protein binding; RB, ribonu-
cleoprotein binding; OB, oxygen binding; LB, lipid binding; ECA, elec-
tron carrier activity; DB, drug binding; CB, carbohydrate binding. (C)
Biological process. MP, metabolic process; T, transport; CCO, cellular
component organization; RTS, response to stimulus; GE, gene expres-
sion; A, apoptosis; DP, developmental process; RCC, regulation of cell
cycle; CH, cellular homeostasis.
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View Article OnlineOther proteins associated with protein synthesis that have
been found up-regulated in our study are eif5a2, eef1a and
hnrnpab. Recent studies38 have indicated that eif5a2 may be
involved in apoptotic pathways; in fact, eif5a2 may have pro-
apoptotic functions. Eef1a has also been found up-regulated in
zebrafish fed with aMeHg-contaminated diet.38 It is an abundant
and ubiquitous cellular protein responsible for the GTP-depen-
dent recruitment of aminoacyl-tRNAs to the ribosome during
the elongation cycle of protein translation and it has been
implicated in facilitating the apoptosis, being essential for the
protein synthesis needed to fuel the machinery required for
apoptosis.38 Our data show that due to MeHg treatment several
molecules related to apoptosis are de-regulated suggesting
increased cell death in the developing organism due to MeHg
treatment.This journal is ª The Royal Society of Chemistry 2012Calcium homeostasis represents a key mechanism of MeHg-
induced toxicity
Calreticulin is a highly conserved multifunctional Ca2+ buffering
chaperone localized in the lumen of the endoplasmatic reticulum
(ER) where it binds to newly synthesized glycoproteins, thus
preventing their aggregation and assisting in their correct protein
folding.41 Increased expression of calreticulin results in elevated
Ca2+ concentrations that cause the ER stress.42 In a previous
study where Atlantic cod was exposed to Hg-enriched sediments,
calreticulin was found significantly up-regulated in gills and liver,
thus suggesting the potential of this protein as an ecotoxicity
marker of exposure to Hg and possibly, to other heavy metals
that may interfere with Ca2+ homeostasis.43
Several parvalbumin proteins such as pvalb2 and pvalb9 were
up-regulated at the two concentrations of MeHg tested, whereas
pvalb1 was down-regulated at the highest dose of MeHg. Par-
valbumins are calcium-binding proteins that have been previ-
ously associated with several clinical disorders such as
Alzheimer’s disease, nervous system disorders, age-related
cognitive defects and some forms of cancers,44 with all of them
also related to the toxic effects associated with MeHg exposure.
In addition, also supporting this fact, a previous study has shown
de-regulation of the genes encoding parvalbumins after exposing
zebrafish to MeHg.30
It is also important to mention the close relationship existing
between the disturbances in calcium homeostasis with the
generation of reactive oxygen species (ROS) in the mitochon-
dria,45 the latter being a well-established effect related to MeHg-
induced cell death.46 The oxidative stress conditions due toMeHg
exposure may accelerate protein degradation by autophagy and by
the ubiquitin-proteasome system. In fact, several proteins related
to lysosomal and autophagic functions such as vitellogenins,
V-ATPase, ER proteins and microtubule-associated proteins were
found de-regulated in our experiment.
MeHg exposure affects the energy production machinery
Several proteins related to energy production such as ckmb and
two ATPases (atp6v1a, atp6v1ba) were found de-regulated after
MeHg exposure. The inactivation of ATPases has been related to
pathological and physiological abnormalities, and with neuro-
degenerative diseases.47 Mercurial compounds, especially MeHg,
have been reported to specifically bind this type of enzyme, thus
suppressing their activity and causing cellular and organic
dysfunction.48 In addition, the induction of oxidative stress,
which is a phenomenon involved in MeHg-induced toxicity, has
also been closely related to the inhibition of ATPase activities,
supporting our findings.49
Other processes affected by MeHg exposure
The results from our iTRAQ experiment, indicate that other
proteins may play an important role in the developmental
toxicity induced by MeHg and the biological processes impli-
cated are as follows: flnb, which is an actin binding protein and
have been previously shown to be altered by exposure to most
heavy metals such as zinc, arsenic, mercury and cadmium,
causing disruption of actin and microtubules in intact cells and
thus, affecting the cellular organization.50 The observedAnalyst, 2012, 137, 5302–5311 | 5309
Fig. 4 Zebrafish larvae treated for 3 consecutive days with methylmercury (5 mg L1 and 25 mg L1) starting at 3 days postfertilization (dpf). (B and C)
The swim bladder is indicated by an asterisk and the upper jaw by an arrow. (D–F) The shape of the brain is outlined by a black line and the fold between
the telencephalon and the tectum is indicated by an arrow. The ear and the liver are outlined by white lines.
Fig. 5 Histological analysis of 6 dpf zebrafish larvae treated for 3 days
with 25 mg L1 methylmercury. (A) Longitudinal section of a 6 dpf
zebrafish control larva showing the trunk region. (B) Longitudinal
section of a 6 dpf zebrafish treated with 25 mg L1 showing the trunk
region. (C) Posterior trunk region of a control 6 dpf zebrafish larva
showing the myotomes (m) and the notochord (n). (D) Posterior trunk
region of a zebrafish larva treated with 25 mg L1 of MeHg.
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View Article Onlineincreased expression of Gstp1, Prdx3 and Pdia4 may be induced
by the oxidative stress conditions. In the case of Gstp1, its up-
regulation is consistent with our previous study carried out in
vitro with HepG2 cells,7 in which an increased GST activity was
observed after 2 h of MeHg exposure and continued increasing
up to 24 h. This increased GST activity could be related to the
cellular detoxification of MeHg41 since GST catalyses the reac-
tion of endogenous GSH with xenobiotics to yield less toxic
conjugates that are easily eliminated.51 Prdx3 is a protein
involved in the antioxidant defense system with an active dithiol
site which is responsible for the reduction of SH groups in several
proteins that have been oxidized under a situation of oxidative
stress. In our experiment, prdx3 appeared up-regulated, thus
showing another potential defense mechanism against MeHg
toxicity.52 Another protein found up-regulated in zebrafish
larvae exposed to 25 mg L1 MeHg was mvp, which is linked to5310 | Analyst, 2012, 137, 5302–5311multidrug resistance; in fact, high levels of mvp have been found
in tissues chronically exposed to xenobiotics. In addition, the
expression of mvp is correlated with the degree of malignancy in
certain types of cancer, suggesting a direct involvement in tumor
development and/or progression.53 Chia was one of the proteins
found with a high iTRAQ ratio in larvae exposed to the highest
concentrations of MeHg. This protein is involved in carbohy-
drate metabolism and so far has only been shown to be induced
in plants exposed to mercury. Moreover, it is known that
up-regulation of glutathione S-transferase (gstp1) may induce
pathogenesis-related proteins such as chitinase,54,55 in agreement
with our results where both glutathione S-transferase and chiti-
nase (chia) have been found over-expressed. Fibronectin, found
up-regulated at 25 ppb MeHg exposure, is a glycoprotein
involved in cell adhesion and migration processes including
embryogenesis, wound healing, blood coagulation and host
defense. In situ hybridation studies show specific enrichment of
this protein in epidermis (ESI, Table S3†).Conclusion
We have applied a quantitative proteomic approach for the
identification of novel protein targets and pathways associated
with the developmental toxicity induced by MeHg in zebrafish.
From the methodological point of view, iTRAQ has been
combined with two different peptide separation techniques (SCX
and IEF) showing a significant increase in the proteome
coverage. Our experiments have identified a number of proteins
whose expression is altered uponMeHg exposure, thus providing
a set of targets closely related to MeHg induced toxicity. This has
allowed us for the identification of crucial biological and
molecular functions affected by MeHg such as embryonic
development, calcium homeostasis, protein synthesis and energy
production. Our findings have correlated well with previous
studies and have also proposed novel targets for future studies,
thus providing a deeper knowledge on the toxicity induced by
MeHg in developing organisms. In addition, the morphological
and histological analyses of zebrafish larvae have supported the
results obtained by our proteomic approach.This journal is ª The Royal Society of Chemistry 2012
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